Rapport Therapeutics (RAPP) EBITDA Margin (2026)
Rapport Therapeutics (RAPP) has 1 years of EBITDA Margin data on record, last reported at 104.54% in Q1 2026.
Rapport Therapeutics (RAPP) has 1 years of EBITDA Margin data on record, last reported at 104.54% in Q1 2026.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month